Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSABP C-01: Adjuvant Chemo or BCG in Colon Cancer
NCT00427570Phase 3Completed
- Sponsor
- NSABP Foundation
- Start
- Sep 1977
- Modality
- Vaccines & Immunotherapeutics, DNA Intercalators/Alkylators, Covalent Small Molecules
01
Overview
Phase 3, randomised, open-label trial of fluorouracil, semustine, vincristine and bcg vaccine in colon cancer (3 arms), sponsored by NSABP Foundation. Primary endpoints: Disease-Free Survival at 10 years and Overall Survival at 10 years. Started Sep 1977; status: completed.
02
Drugs
fluorouracilsemustinevincristinebcg vaccine
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00427570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427570.